The effects of sertraline on blood lipids, glucose, insulin and HBA1C levels: A prospective clinical trial on depressive patients
JOURNAL OF RESEARCH IN MEDICAL SCIENCES, vol.16, no.12, pp.1525-1531, 2011 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 16 Issue: 12
- Publication Date: 2011
- Journal Name: JOURNAL OF RESEARCH IN MEDICAL SCIENCES
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Page Numbers: pp.1525-1531
- Keywords: Sertraline, Insulin, Glucose, Lipid, HbA1C, SEROTONIN REUPTAKE INHIBITORS, DISORDER, ANTIDEPRESSANTS, SENSITIZATION, CHOLESTEROL, FLUOXETINE, GLYCEMIA, SUCROSE, MEAL, RATS
- Karadeniz Technical University Affiliated: Yes
Abstract
BACKGROUND: In this study, we aimed to investigate the possible effects of sertraline on blood glucose and lipid levels as risk factors for cardiovascular disease in depressive patients.